Search
for
Sort by
Research 121–150 of 1000+
- Analysis of androgen receptor expression and activity in the mouse brain
- Type 2 Diabetes, Metabolic Syndrome and Lipid Metabolism
- Interferon alfa-2a in the treatment of cutaneous T cell lymphoma
- Vasoactive intestinal peptide, whose receptor-mediated signalling may be defective in alopecia areata, provides protection from hair follicle immune privilege collapse
- Toll-like Receptor 3 Agonist, Polyinosinic-polycytidylic Acid, Upregulates Carbonic Anhydrase II in Human Keratinocytes
- Monoclonal Antibody Against Prolactin Receptor: A Randomized Placebo-Controlled Study Evaluating Safety, Tolerability, and Pharmacokinetics of Repeated Subcutaneous Administrations in Postmenopausal Women
- Analysis of Vitamin D Receptor (VDR) Gene Polymorphisms in Alopecia Areata
- Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer
- Realising the therapeutic potential of neuroactive steroid modulators of the GABAA receptor
- Lymphoid Enhancer-binding Factor-1 (LEF1) Interacts with the DNA-binding Domain of the Vitamin D Receptor
- Vitamin D receptor polymorphisms and the polycystic ovary syndrome: A systematic review
- Cell wall-associated ROOT HAIR SPECIFIC 10, a proline-rich receptor-like kinase, is a negative modulator of Arabidopsis root hair growth
- Glucocorticoid Receptor Mutants Demonstrate Increased Motility Inside the Nucleus of Living Cells: Time of Fluorescence Recovery After Photobleaching (FRAP) Is an Integrated Measure of Receptor Function
- 5alpha-reductase inhibitors dampen L-DOPA-induced dyskinesia via normalization of dopamine D1-receptor signaling pathway and D1-D3 receptor interaction
- Androgen receptor modulators: a review of recent patents and reports (2012-2018)
- <i>In Vitro</i>and<i>in Vivo</i>Structure-Activity Relationships of Novel Androgen Receptor Ligands with Multiple Substituents in the B-Ring
- The 5alpha-reductase type 1, but not type 2, gene is expressed in anagen hairs plucked from the vertex area of the scalp of hirsute women and normal individuals
- Effectiveness and Safety of Botulinum Toxin Type A in the Treatment of Androgenetic Alopecia
- Melatonin Receptors and Their Role in Human Diseases
- Glucocorticoid and Sex Hormone Receptors: Clinical Implications and Therapeutic Relevance
- Androgen Receptor Ligands: Agonists and Antagonists
- Evaluation of the role of soluble receptors for advanced glycosylated end-products in polycystic ovarian syndrome
- Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment
- Cachexia and graft-vs.-host-disease-type skin changes in keratin promoter-driven TNF alpha transgenic mice.
- Androgen Receptor Antagonists (Antiandrogens) Structure-Activity Relationships
- A Novel Point Mutation in the Ligand-Binding Domain (LBD) of the Human Glucocorticoid Receptor (hGR) Causing Generalized Glucocorticoid Resistance: The Importance of the C Terminus of hGR LBD in Conferring Transactivational Activity
- Androgen Receptor Accelerates Premature Senescence of Human Dermal Papilla Cells in Association with DNA Damage
- Cross-species sensitivity to a novel androgen receptor agonist of potential environmental concern, spironolactone
- Prostaglandin D2-Mediated DP2 and AKT Signal Regulate the Activation of Androgen Receptors in Human Dermal Papilla Cells
- Development of fluridil, a topical suppressor of the androgen receptor in androgenetic alopecia